All Updates

All Updates

icon
Filter
Product updates
Libre Foods unveil “EU’s first” mushroom bacon
Plant-based Meat
Feb 14, 2023
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Plant-based Meat

Plant-based Meat

Feb 14, 2023

Libre Foods unveil “EU’s first” mushroom bacon

Product updates

  • Spanish biotech startup specializing in mycelium-based alternative meats, Libre Foods, has debuted a vegan bacon made from mushrooms, which according to the company is the first of its kind to launch in the EU.

  • As opposed to bacon made from mycelium (root structure of fungi), this bacon product is made from the mushroom (body of the fungus) itself and is claimed to contain 70% fewer fats, 52% fewer calories, and 18% less salt than traditional bacon. The mushroom bacon is slated to initially launch at Burger restaurants in the Spanish cities of Barcelona, Madrid, and Valencia.

  • The company will continue its efforts in developing mycelium-based steak and chicken alternatives, although these products’ marketability will depend on receiving regulatory approval as mycelium is considered a novel ingredient in the EU.

  • AnalystQuickTake: According to the EFSA, a novel ingredient is defined as “any food that was not consumed significantly before May 1997” and any food ingredient which does not fall into this category will require pre-market authorization. Given that mycelium does not fall into this definition, there has been a lack of mycelium-based products entering EU countries, due to the time and cost a company has to spend to receive approval. On the other hand, in the US, Mycelium has received GRAS status making the US a more favorable market for mycelium-based alternative producers. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.